ACE2 and COVID-19: We used hACE2 knock-in mice that are susceptible to SARS-CoV-2 infection37, in which the endogenous mouse ACE2 is replaced by hACE2 and thereby more likely mimic the levels and distribution of hACE2 expression encountered in humans.